Cefodizime Sodium

Producers shown on SFDA

(Record date:03/09/2021）

Producers shown on EP

Not showing any

Producer:Sinopharm Shantou Jinshi Pharmaceutical Co., Ltd. (formerly Shantou Jinshi Pharmaceutical General Factory) is now a wholly-owned subsidiary of Shanghai Modern Pharmaceutical Co., Ltd.

The enterprise covers an area of more than 36 Mu and a construction area of more than 20000 square meters. Its production scope includes chemical APIs, sterile APIs, tablets, hard capsules, powder injections, granules, dry suspensions, oral liquids and oral solutions. It has independently developed, developed and produced 154 approvals, including 142 preparations and 12 APIs; The Department and all its production lines (nine dosage forms and seven workshops in total) have passed the new version of GMP certification.

Staff size:400-499 persons

Registered capital:RMB 83.98 million

Producer:Established in 2007, Amicogen (China) Biopharm Co., Ltd. （Previous named as Shandong Lukang Record Pharmaceutical Co., Ltd.）is an emerging pharmaceutical company in China. We develop and manufacture API, intermediate and fine chemicals in accordance with related GMP. Our facility is subjected to a strict adherence to environment, health and safely program and has been certificated with ISO9000、ISO14000 and OSHMS.Amicogen (China) has US FDA,Japan PMDA, Europe MRP certification and most products have GMP certification. 
Staff size:600-699 persons

Registered capital:RMB 85.3 million

Producer:Established in 2007, Amicogen (China) Biopharm Co., Ltd. （Previous named as Shandong Lukang Record Pharmaceutical Co., Ltd.）is an emerging pharmaceutical company in China. We develop and manufacture API, intermediate and fine chemicals in accordance with related GMP. Our facility is subjected to a strict adherence to environment, health and safely program and has been certificated with ISO9000、ISO14000 and OSHMS.Amicogen (China) has US FDA,Japan PMDA, Europe MRP certification and most products have GMP certification. 

Staff size:600-699 persons

Registered capital:RMB 85.3 million

Producer:Livzon Syntpharm Co.,Ltd.， a wholly-owned subsidiary of Lizhu Pharmaceutical Group Co., Ltd., was established in 1993 and is located in Zhuhai Free Trade Zone, Guangdong Province. By the end of 2008, the company had invested more than 300 million yuan in fixed assets, covering an area of about 100000 square meters. It is a API base based on cephalosporin semi synthetic antibiotics built according to GMP standards. The production lines of the whole company have passed GMP certification.

The company has nearly 500 employees. Its main products include ceftriaxone sodium, cefuroxime sodium, cefdixone sodium, ceftazidime, cefepime hydrochloride and cefpirome sulfate. The total annual capacity is 680 tons. The production process and economic and technical indexes of all products have reached the domestic advanced level, and the product quality meets the CP and USP Pharmacopoeia standards.

Staff size:400-499 persons

Registered capital:RMB 128.28 million

Producer:Zhejiang Dongying Pharmaceutical Co., Ltd. was established in 2005 and was wholly acquired by Zhejiang Guobang Pharmaceutical Co., Ltd. in March 2013. All products of the company have passed the national pharmaceutical GMP certification and are committed to the R & D, production and operation of cephalosporin antibiotics. It has an annual production capacity of 150 tons of cephalosporin sterile API, 600 tons of oral cephalosporin API and 1000 tons of pharmaceutical intermediates.
Staff size:100-199 persons

Registered capital:RMB 234 million 57 thousand and 776

Producer:Liaoning Meiya Pharmaceutical Co., Ltd. is subordinate to the antibiotic division of Shanghai Pharmaceutical Group, which was established in 2002. Covering an area of 114.000 m2, it is divided into two production areas. One is the pharmaceutical intermediate production area, covering an area of 34000m2. There are five synthesis workshops, mainly producing cephalosporin pharmaceutical intermediates and other intermediates. It passed ISO9001 (2000) certification in 2003; The other is the API production area, covering an area of 80000m2. There is a synthesis workshop and aseptic workshop. The aseptic workshop has six production lines. It passed the GMP certification of China in February 2005. At present, the production capacity of sterile cephalosporin API is up to 500 tons / year, and the production capacity of pharmaceutical intermediates is up to 700 tons / year.
Staff size:400-499 persons

Registered capital:RMB 300 million

Producer:Zhejiang Yongning Pharmaceutical Co., Ltd., located in Taizhou, Zhejiang Province, has more than 100 product varieties in five categories, including chemical agents, chemical pharmaceutical intermediates, APIs, Chinese patent medicines and health products.   The company has fully passed the new national GMP certification, and some products have passed the certification of FDA, PMDA of Japan and KFDA of Korea, among which cefotiam hydrochloride is the standard of USP.
Staff size:900-999 persons

Registered capital:RMB 153.125 million

Producer:Shandong Luoxin Pharmaceutical Group Hengxin Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Luoxin Pharmaceutical Group Co., Ltd.

Luoxin Pharmaceutical Group Co., Ltd. is a large pharmaceutical enterprise group integrating drug R & D, production, trade and medical and health services.

At present, the company has four manufacturing bases, including more than 50 production lines, including powder injection, lyophilized powder injection, solid preparation (including cephalosporins), spray, aerosol, pre encapsulation, large capacity injections, small volume injections, chemical raw materials, cephalosporins, and so on. There are more than ten dosage forms and more than 300 product specifications on the market. There are 48 national new drugs. The company can produce 1 billion powder injections, 500 million freeze-dried powder injections, 400 million large bottles of injections (bags), 500 million small volume injections, 7 billion tablets, 2 billion capsules, 300 million capsules, 80 million dry suspensions, 300 tons of micro pills, 1000 tons of raw materials, 30 million aerosol cans, spray ingredients, and pre encapsulated branches.
Staff size:RMB 50 million

Registered capital:700-799 persons

Producer:Shenzhen Salubris Pharmaceuticals Co., Ltd., established in 1998 and listed on Shenzhen Stock Exchange in 2009, is a comprehensive pharmaceutical listed company integrating pharmaceutical product R & D, production and sales. The company accurately distributes the global industrial chain, covering more than 30 countries and regions such as China, the United States, Germany, France and Japan. All products and production workshops of the company have passed the domestic GMP certification, Daya Bay production base has passed the EU GMP certification, and the key product Taijia has obtained the listing license of 12 EU countries. All kinds of products enjoy a good reputation in the industry.
Staff size:About 3500 persons

Registered capital:RMB 1 billion 115 million

Producer:Qilu Antibiotics Pharmaceutical Co., Ltd.was established in 1995, specializing in the production of cephalosporin APIs. It has three series of products: sterile APIs, oral APIs and pharmaceutical intermediates. The company has 26 listed varieties.

The company is the first in the same industry in China to pass the GMP certification in China and the EDQM certification in the European Union, and has successfully passed the official certification of Australia TGA, the FDA of the United States, Japan PMDA, South Korea MFDs, Britain EDQM, Cyprus MOH and Brazil Anvisa. It has obtained 11 CEP certificates for cephalosporins including the world's first CEP certificate. At present, there are 16 CEP certificates in China.

Staff size:2000-2999 persons

Registered capital:USD 319.27 million

Producer:Guangxi Kelun Pharmaceutical Co., Ltd. (formerly Guilin Dahua), now subordinate to Sichuan Kelun Pharmaceutical Co., Ltd., founded on November 22, 1996, is a manufacturer of cephalosporin antibiotic API and powder injection. The plant covers a total area of 79847.29 square meters, including a construction area of 14599.49 square meters. Guangxi Kelun became the first batch of GMP compliant units in 1999. At present, the factory is the only production base of cephalosporin antibiotics in Guangxi, which is fully equipped from API to preparation.

Staff size:400-499 persons

Registered capital:RMB 60 million